We have one clear and simple focus: research. Research is what saves lives and research is the only way to eradicate breast cancer. That is why it is important that BCRF continues to direct much-needed funds - $40 million this year alone - to creative, collaborative global research initiatives that enable a brain trust of 197 talented investigators to unravel the mysteries of breast cancer and to empower them with the tools to resolve this insidious disease.
We are united in
our shared responsibility to fund research, our shared demand that it adheres to the highest standards, and our shared responsibility to ensure that its benefits are translated to the clinic, for the patients who need it.
Under the leadership of our expert team of Scientific Advisors, we have compiled a broad and diverse array of research experts who are guiding lights in the field. BCRF-funded projects have brought about great leaps
in breast cancer care. In order to sustain this cohort of talented scientists, we must continue to invest in their efforts and analytical
knowledge as we are confident that the projects within our research portfolio are bringing us closer to our goal, and shedding light
on many other cancers as well.
I am very proud to acknowledge the many advances in breast cancer that have come about as a result of BCRF-funded research. But there is still work to be done. This disease continues to claim nearly 500,000 lives around the globe annually. It is because of your dedicated support and investment in scientific progress that BCRF investigators will be able to change lives by saving lives.
Myra J. Biblowit
BCRF President, Myra Biblowit, receives 2012 Woman of Achievement Award